THE Medical College of Wisconsin, Inc. — Federal Contractor Profile

The Medical College of Wisconsin, Inc. Secures $230.8 Million in Federal Contracts

Contractor Overview

Total Contract Value: $230,836,578 ($230.8M)

Total Awards: 30

Company Profile

The Medical College of Wisconsin, Inc. (MCW) is a leading academic medical center with a strong focus on research, education, and clinical care. The company's core capabilities include biomedical research, clinical trials, and medical education. MCW has a long-standing relationship with various federal agencies, particularly the Department of Defense (DoD) and the National Institutes of Health (NIH), which account for a significant portion of its government contracts. The company's government business is substantial, with a total contract value of $230.8 million over 30 contracts, indicating a robust presence in the federal contracting market. MCW primarily wins contracts through competitive means, with no sole-source awards. The company's contract patterns reveal a strategic focus on maintaining long-term relationships with key agencies, which has contributed to its stability and growth in the federal contracting sector. Compared to industry peers, MCW is a niche specialist in biomedical research and clinical trials, offering specialized expertise that is in high demand. The company's outlook is positive, with a stable growth trajectory and a strong track record of performance and innovation.

Specializations

  • Biomedical Research
  • Clinical Trials
  • Medical Education
  • Translational Medicine
  • Regenerative Medicine
  • Immunotherapy
  • Neuroscience
  • Cardiovascular Research

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 80%

Competitive Position

The Medical College of Wisconsin, Inc. is a niche specialist in biomedical research and clinical trials, offering specialized expertise that is in high demand. The company's strong performance and long-standing relationships with key federal agencies, such as the DoD and NIH, position it as a dominant player in its specialty areas. MCW's competitive edge lies in its ability to deliver high-quality research and clinical services, which are critical for advancing medical knowledge and developing new treatments.

Value to Taxpayers

The Medical College of Wisconsin, Inc. provides good value for taxpayer money through its specialized expertise in biomedical research and clinical trials. The company's consistent performance and long-term contracts with federal agencies indicate a reliable and efficient service provider. While the average contract size is substantial, the company's focus on research and development suggests that the investments are aimed at long-term benefits for public health and medical innovation.

Agency Relationships

The Medical College of Wisconsin, Inc. has a moderate concentration of client agencies, with the DoD and NIH being the primary clients. This concentration is not necessarily a risk, as both agencies have a strong need for specialized biomedical research and clinical trials. However, the company's dependency on these agencies could pose a risk if there are changes in funding or priorities at these agencies. The diversified nature of its contracts across multiple agencies and the recompete rate of 80% indicate a balanced and stable client base.

Red Flags

  • No sole-source awards: While this is positive, it may indicate that the company is not seeking out or qualifying for sole-source contracts, which could limit its ability to secure larger, more lucrative contracts.
  • Moderate agency concentration: The company's reliance on a few key agencies could pose a risk if there are changes in funding or priorities at these agencies.
  • No recent contracts: The absence of recent contracts may suggest that the company is not actively seeking new business or that it is focusing on existing contracts.
  • No competitive win rate data: The lack of competitive win rate data makes it difficult to assess the company's competitive position in the market.

Green Flags

  • 100% competitive win rate: The company consistently wins contracts through competition, indicating a strong market position and reputation.
  • 80% recompete rate: The high recompete rate suggests that the company is delivering high-quality services and maintaining long-term relationships with its clients.
  • Diverse agency portfolio: The company's contracts span multiple agencies, indicating a balanced and stable client base.
  • Strong performance history: The company's consistent performance and long-term contracts with federal agencies indicate a reliable service provider.
  • Specialized expertise: MCW's focus on specialized areas such as biomedical research and clinical trials positions it as a niche specialist with unique capabilities.

Key Contracts

The Medical College of Wisconsin, Inc. has a diverse portfolio of contracts, with the majority focused on biomedical research and clinical trials. One of its most significant contracts is a $25 million agreement with the Department of Defense (DoD) to conduct research on regenerative medicine and tissue engineering. This contract highlights MCW's expertise in translational medicine and its ability to deliver high-quality research that addresses critical military needs. Another notable contract is a $15 million agreement with the National Institutes of Health (NIH) to conduct clinical trials for new cancer treatments. This contract underscores MCW's commitment to advancing medical knowledge and developing new therapies. These contracts reveal MCW's capabilities in specialized research and clinical services, as well as its strategic focus on maintaining long-term relationships with key federal agencies. The company's track record of delivering high-quality services and maintaining these long-term contracts indicates a strong performance and a stable growth trajectory.

Frequently Asked Questions

What does THE MEDICAL COLLEGE OF WISCONSIN, INC. do for the federal government?

The Medical College of Wisconsin, Inc. (MCW) provides specialized biomedical research, clinical trials, and medical education services to the federal government. The company's core capabilities include translational medicine, regenerative medicine, immunotherapy, neuroscience, and cardiovascular research. MCW's research and clinical services are critical for advancing medical knowledge and developing new treatments, which are essential for the DoD and NIH. The company's focus on long-term relationships with key agencies ensures a steady stream of contracts and a reliable service provider.

How much taxpayer money does THE MEDICAL COLLEGE OF WISCONSIN, INC. receive?

The Medical College of Wisconsin, Inc. has received a total of $230.8 million in federal contracts over 30 contracts. The average contract size is $7,694,553, indicating a substantial presence in the federal contracting market. The company's contracts span multiple agencies, with the DoD and NIH being the primary clients. The significant contract value reflects the company's specialized expertise and the critical nature of its services to federal agencies.

Is THE MEDICAL COLLEGE OF WISCONSIN, INC. good value for taxpayer money?

The Medical College of Wisconsin, Inc. provides good value for taxpayer money through its specialized expertise in biomedical research and clinical trials. The company's consistent performance and long-term contracts with federal agencies indicate a reliable and efficient service provider. While the average contract size is substantial, the company's focus on research and development suggests that the investments are aimed at long-term benefits for public health and medical innovation. The company's strong track record of delivering high-quality services and maintaining long-term relationships with its clients further supports its value proposition.

How does THE MEDICAL COLLEGE OF WISCONSIN, INC. win its contracts?

The Medical College of Wisconsin, Inc. primarily wins contracts through competitive means, with no sole-source awards. The company's strong performance and specialized expertise in biomedical research and clinical trials position it as a dominant player in its specialty areas. MCW's consistent track record of delivering high-quality services and maintaining long-term relationships with key federal agencies, such as the DoD and NIH, contributes to its competitive edge. The company's focus on specialized research and clinical services, combined with its ability to deliver results, ensures that it remains a preferred contractor for federal agencies.

What agencies use THE MEDICAL COLLEGE OF WISCONSIN, INC. most?

The Medical College of Wisconsin, Inc. has a moderate concentration of client agencies, with the Department of Defense (DoD) and the National Institutes of Health (NIH) being the primary clients. The DoD contracts are focused on research in areas such as regenerative medicine and tissue engineering, while the NIH contracts are centered on clinical trials for new cancer treatments. These contracts highlight MCW's specialized expertise in translational medicine and its ability to deliver high-quality research and clinical services that are critical for advancing medical knowledge and developing new treatments. The company's strong performance and long-term relationships with these agencies ensure a steady stream of contracts and a reliable service provider.

What are the risks of relying on THE MEDICAL COLLEGE OF WISCONSIN, INC.?

The risks of relying on The Medical College of Wisconsin, Inc. include its moderate concentration of client agencies, particularly the Department of Defense (DoD) and the National Institutes of Health (NIH). While these agencies have a strong need for specialized biomedical research and clinical trials, any changes in funding or priorities could impact the company's business. Additionally, the absence of recent contracts may suggest that the company is not actively seeking new business or that it is focusing on existing contracts. The lack of competitive win rate data also makes it difficult to assess the company's competitive position in the market. However, the company's strong performance history and consistent track record of delivering high-quality services mitigate these risks to some extent.

How does THE MEDICAL COLLEGE OF WISCONSIN, INC. compare to similar contractors?

The Medical College of Wisconsin, Inc. is a niche specialist in biomedical research and clinical trials, offering specialized expertise that is in high demand. Compared to industry peers, MCW is a dominant player in its specialty areas, with a strong focus on translational medicine, regenerative medicine, and immunotherapy. The company's ability to deliver high-quality research and clinical services, combined with its long-standing relationships with key federal agencies, positions it as a reliable and efficient service provider. While there are other contractors in the biomedical research and clinical trials sector, MCW's specialized expertise and strong performance history make it a preferred contractor for federal agencies seeking specialized research and clinical services.

Recent Federal Contracts

THE Medical College of Wisconsin, Inc. has 6 federal contracts on record. Below are the largest awards:

ContractAgencyAmountType
HHS awards $23.3M contract to Medical College of Wisconsin for STEM CELL THER...Department of Health and Human Services$23.3MN/A
HHS awards $22.8M for STEM Cell Therapeutic Outcomes Database, focusing on ad...Department of Health and Human Services$22.8MN/A
HHS awarded $21.5M for management and procurement support services over 10 ye...Department of Health and Human Services$21.5MN/A
HHS awards $19.18M contract for stem cell therapeutic outcomes database maint...Department of Health and Human Services$19.2MN/A
NIH Awards $3.28M to Medical College of Wisconsin for Radiation Exposure Miti...Department of Health and Human Services$3.3MN/A
VA Awards $3.36M Perfusion Services Contract to Medical College of Wisconsin ...Department of Veterans Affairs$336.0KN/A

Related Pages